Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Buy Nokia Stock Despite the 18.5% Bounce from Lows

By Chris Lau, InvestorPlace Contributor

Nokia is still trading at a steep discount as investors fail to recognize the long-term growth in its 5G business.

7 Short-Term Stocks to Trade as a Present to Yourself Before the Year Ends

By Chris Lau, InvestorPlace Contributor

Investors still have a few weeks left of trading, after spectacular returns so far in the year. Here are 7 short-term ideas.

XPeng Stock Had a Wild Run, but It Looks Ready to Top Out Here

By Chris Lau, InvestorPlace Contributor

Investors need to decide if they should sell XPeng to book profits or to let the stock rise further.

Covid-19 Vaccine Makers Still Make Sense, Including Sorrento Therapeutics

By Chris Lau, InvestorPlace Contributor

SRNE stock fell out of favor as bigger vaccine developers grabbed the headlines but that may change soon.

Watch Out for a Correction in PLUG Stock

By Chris Lau, InvestorPlace Contributor

Plug Power raised a billion dollars in capital and markets did not react, which is dangerous if sentiment suddenly turns negative.

Load More